Investing Profile

Diyong Xu

InvestorVC
Principal at Orbimed
orbimed.comNew York, New York
Photo of Diyong Xu, Principal at OrbiMed

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
OrbiMed Principal
$1M - $75.0M
$4.0M
4
$18B
CompanyStageDateRound SizeTotal Raised
Q32 Bio
Post Ipo EquityMar 2024$42M
Series BOct 2020$60M
Series AMay 2020$46M
$190M
Co-investors: David Grayzel (Atlas Venture), Isaac Manke (Acorn Bioventures)
OnCusp Therapeutics
Series AJan 2024$100M
$100M
Co-investors: Chong Xu (F-Prime Capital Partners), Karen Hong (Novo Ventures)